Back to Dashboard

DREAMM-10(214828)

MM•NCT06679101•Last updated: 2/17/2026

Recruiting

Study Design

Study Drug

belantamab mafodotin+Lena+Dexa

Mechanism of Action

BCMA

Sponsor

Unknown

Design

III

Control Arm

DRd

Criteria

Inclusion Criteria

1. Newly diagnosed MM 2. ineligible for ASCT

Age: Phase: III

Exclusion Criteria

Enrollment

Progress3 / 5

Contact Information

Principal Investigator

Unknown

Study Nurse

鄭采涵

Contact Tel

3974